Testing new antiviral agents against respiratory viruses in the lab
Official title: Task B25: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses
Funded at Utah State University · NIH-11202351 · Data updated 2026-11-12
This study is looking at new medicines that might help fight off common respiratory viruses, like the ones that cause colds, to find better treatments for people who get sick from these infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State University NIH-funded |
| Lab location | 1 site (Logan, United States) |
| Project start | September 23, 2024 |
| Project end | September 22, 2025 |
| Funding year | 2024 |
| Award (this year) | $22,948 |
| NIH project number | 75N93019D00021-0-759302400002-1 |
| Project ID | NIH-11202351 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from respiratory viral infections or those at high risk of such infections.
✕Less likely to help
Patients with bacterial infections or those not affected by respiratory viruses may not receive any benefit from this research.
What this research studies
This research focuses on evaluating the effectiveness of potential antiviral agents against respiratory viruses, such as respiratory syncytial virus and rhinovirus, using cultured cell lines in a laboratory setting. The approach involves maintaining viral stocks and developing assays to assess the antiviral activity of these compounds. Patients can benefit from this research as it aims to identify new treatments that could help combat viral infections affecting the respiratory system.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral medications that effectively treat respiratory viral infections.
How similar studies have gone: Other research has shown success in developing antiviral agents through similar in vitro testing approaches, indicating a promising avenue for new treatments.
Where this research is happening
-
Utah State University
Logan, United States Active
Researchers
- Principal investigator: Hurst, Brett — Utah State University
- Study coordinator: Hurst, Brett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.